Multiple reports present an eventful period for
The Cigna Group (CI) with highlights ranging from financial performance to changes in asset management. The firm released its Q4 and full year 2024 results and set its earnings outlook for 2025, with an increase in dividends. Despite cost challenges, the company experienced
strong revenue growth, prompting the price target to be adjusted several times by analysts from Oppenheimer, Stephens, Cantor Fitzgerald, Barclays, and more. Several notable asset managers have adjusted their holdings in Cigna, with entities like Swedbank AB and Highland Capital Management LLC buying shares, while others, like SG Americas Securities and Robeco Institutional Asset Management BV, selling. Despite missing the earnings estimates for Q4, Cigna shares saw an increase of 5.4%. Interestingly, Cigna announced the appointment of a
new Chief Medical Officer for its Healthcare division. Amid these developments, the market outlook on The Cigna Group ranges from bearish to bullish, with some investors considering the current situation an opportunity to buy.
The Cigna Group CI News Analytics from Thu, 31 Oct 2024 07:00:00 GMT to Sat, 01 Feb 2025 22:10:23 GMT -
Rating 7
- Innovation 2
- Information 4
- Rumor 1
